US EditionBlood Pressure Medication Recalled Over Cancer Risk
21 Articles
21 Articles
More High Blood Pressure Drugs Recalled Due to Potential Carcinogens, FDA Says
The Food and Drug Administration confirmed in several notices that a recall of a type of high blood pressure medication has been expanded due to the presence of a potentially carcinogenic substance. In three notices issued this week, the FDA confirmed that 7,198 cartons of prazosin hydrochloride are being recalled nationwide by Ohio-based Amerisource Health Services and classified the recall as Class II. N-nitroso prazosin, a nitrosamine found i…
InsideNoVA.com
Blood Pressure Medication Recalled Over Cancer Risk
Key Takeaways
Drug prices in the US are under cross-party political observation, but large drug manufacturers are adapting by making small concessions and looking for new sources of revenue. These developments will inevitably have an impact on European markets.
Coverage Details
Bias Distribution
- 36% of the sources are Center, 36% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium
